Science and Exploration

Shotgun Metagenomics

4 articles

Editorial illustration for Shotgun Metagenomics vs. Metatranscriptomics: Choosing Between a Microbiome's Potential and Its Activity
Life Sciences

Shotgun Metagenomics vs. Metatranscriptomics: Choosing Between a Microbiome's Potential and Its Activity

Shotgun metagenomics sequences DNA to reveal a microbial community's genetic potential and composition, acting as a 'static map'. Metatranscriptomics sequences RNA to show real-time gene expression and activity, providing a 'dynamic image'.

Sofia Petrova·October 31, 2026
Editorial illustration for Choosing the Right Ancient DNA Source and Method for Ecosystem Reconstruction
Life Sciences

Choosing the Right Ancient DNA Source and Method for Ecosystem Reconstruction

Ancient DNA analysis reconstructs past ecosystems by matching source material like sediments and archaeological remains with sequencing methods such as metabarcoding and shotgun metagenomics to address specific ecological questions. This approach provides crucial data for informing conservation decisions and forecasting ecosystem trajectories.

Dr. Elena Ortiz·October 27, 2026
Editorial illustration for Who Is There, What Can They Do, or What Are They Doing? Choosing a Human Microbiome Analysis Method
Life Sciences

Who Is There, What Can They Do, or What Are They Doing? Choosing a Human Microbiome Analysis Method

Choosing the right human microbiome analysis method—16S rRNA sequencing, shotgun metagenomics, or metatranscriptomics—is crucial for obtaining meaningful biological insights, as each method answers a distinct question about community composition, potential, or activity.

Sofia Petrova·October 21, 2026
Editorial illustration for Shotgun vs. Targeted Capture: Choosing the Right Tool to Uncover Ancient Diseases
Human Origins

Shotgun vs. Targeted Capture: Choosing the Right Tool to Uncover Ancient Diseases

Scientists must choose between broad, untargeted shotgun metagenomics for discovering unknown ancient pathogens and sensitive, targeted DNA capture for screening known agents. This decision depends on the research question, sample quality, and cost, balancing discovery versus focused screening.

Dr. Elena Ortiz·October 7, 2026